Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.
Urology. 2012 Dec;80(6):1319-25. doi: 10.1016/j.urology.2012.06.080. Epub 2012 Oct 26.
Urology. 2012.
PMID: 23107099
Free PMC article.
Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy.
Moul JW, Chen DY, Trabulsi EJ, Warlick CA, Ruckle HC, Porter JR, Yoshida JS, Adams GW, Kella N, Matsunaga GS, Bans LL, Sarno MJ, McDermed JE, Triebell MT, Reynolds MA; investigators of the ProsVue Field Experience Trial.
Moul JW, et al. Among authors: triebell mt.
Prostate Cancer Prostatic Dis. 2014 Sep;17(3):280-5. doi: 10.1038/pcan.2014.25. Epub 2014 Jul 15.
Prostate Cancer Prostatic Dis. 2014.
PMID: 25027863
Item in Clipboard
NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy.
Moul JW, Sarno MJ, McDermed JE, Triebell MT, Reynolds MA.
Moul JW, et al. Among authors: triebell mt.
Urology. 2014 Dec;84(6):1427-32. doi: 10.1016/j.urology.2014.07.059.
Urology. 2014.
PMID: 25432832
Item in Clipboard
Cite
Cite